Your browser doesn't support javascript.
loading
Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies.
Roumelioti, Maria-Eleni; Trietley, Gregory; Nolin, Thomas D; Ng, Yue-Harn; Xu, Zhi; Alaini, Ahmed; Figueroa, Rocio; Unruh, Mark L; Argyropoulos, Christos P.
Afiliación
  • Roumelioti ME; Nephrology Division, Department of Medicine, University of New Mexico, Albuquerque, NM, USA.
  • Trietley G; Department of Pharmacy and Therapeutics, Renal-Electrolyte Division, University of Pittsburgh Schools of Pharmacy and Medicine, Pittsburgh, PA, USA.
  • Nolin TD; Department of Medicine, University of Pittsburgh Schools of Pharmacy and Medicine, Pittsburgh, PA, USA.
  • Ng YH; Department of Pharmacy and Therapeutics, Renal-Electrolyte Division, University of Pittsburgh Schools of Pharmacy and Medicine, Pittsburgh, PA, USA.
  • Xu Z; Department of Medicine, University of Pittsburgh Schools of Pharmacy and Medicine, Pittsburgh, PA, USA.
  • Alaini A; Nephrology Division, Department of Medicine, University of New Mexico, Albuquerque, NM, USA.
  • Figueroa R; Nephrology Division, Department of Medicine, University of New Mexico, Albuquerque, NM, USA.
  • Unruh ML; Nephrology Division, Department of Medicine, University of New Mexico, Albuquerque, NM, USA.
  • Argyropoulos CP; Nephrology Division, Department of Medicine, University of New Mexico, Albuquerque, NM, USA.
Nephrol Dial Transplant ; 33(6): 1025-1039, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29186592
ABSTRACT

Background:

Recent meta-analyses suggest that higher removal of beta-2 microglobulin (ß2M) with either high-flux (HFD) dialysis or hemodiafiltration (HDF) may be associated with decreased total and cardiovascular mortality in dialysis patients. However, there are limited data about the performance of high flux dialyzers and/or convective therapies in removing ß2M.

Methods:

This is a random effects meta-analysis and meta-regression of data extracted from randomized controlled trials and observational studies in hemodialysis, hemofiltration and HDF regarding the efficiency of high flux dialyzers to remove ß2M. Studies were searched using ProQuest in SCOPUS, EMBASE and MEDLINE.

Results:

We included 69 studies from 1 January 2001 to 12 June 2017 on 1879 patients with 6771 available measurements. Average ß2M clearance was 48.75 mL/min [95% confidence interval (CI) 42.50-55.21] for conventional HF dialysis, and 87.06 mL/min (95% CI 75.08-99.03) for convective therapies (hemofiltration and HDF) with substantial heterogeneity among studies [P (Q) ≤ 0.001]. In multivariable meta-regression analyses, we found significantly higher ß2M clearance for polyarylethersulfone dialyzers when used for HFD and polysulfone membranes in convective therapies. However, the mass of ß2M removed into the dialysate did not depend on membrane material. Adjusted dialysate-side (-22.279, 95% CI -9.8 to -34.757, P < 0.001) ß2M clearances were significantly lower than whole blood clearances, suggesting that adsorption contributes substantially to ß2M removal. Higher Kuf, blood flow and substitution fluid rates but not dialysate flow rates were associated with statistically significant and clinically meaningful elevation in ß2M clearance from the body independent of the dialysis modality.

Conclusions:

Membrane composition and characteristics, modality (convective versus diffusive), blood flow rates and substitution fluid rates in HDF play a significant role in the efficient removal of ß2M from the body in both diffusive and convective dialysis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Microglobulina beta-2 / Diálisis Renal / Hemodiafiltración / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Observational_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Nephrol Dial Transplant Asunto de la revista: NEFROLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Microglobulina beta-2 / Diálisis Renal / Hemodiafiltración / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Observational_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Nephrol Dial Transplant Asunto de la revista: NEFROLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos